145 related articles for article (PubMed ID: 27520559)
1. The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.
Ciresi A; Radellini S; Guarnotta V; Giordano C
Endocrine; 2017 Jun; 56(3):579-588. PubMed ID: 27520559
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity.
Pasarica M; Zachwieja JJ; Dejonge L; Redman S; Smith SR
J Clin Endocrinol Metab; 2007 Nov; 92(11):4265-70. PubMed ID: 17785361
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index.
Di Somma C; Ciresi A; Amato MC; Savastano S; Savanelli MC; Scarano E; Colao A; Giordano C
Endocrine; 2015 Jun; 49(2):492-502. PubMed ID: 25381601
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
[TBL] [Abstract][Full Text] [Related]
5. Insulin sensitivity and β-cell function in adults with lifetime, untreated isolated growth hormone deficiency.
Oliveira CR; Salvatori R; Barreto-Filho JA; Rocha IE; Mari A; Pereira RM; Campos VC; Menezes M; Gomes E; Meneguz-Moreno RA; Araújo VP; Leite NT; Nascimento-Junior AC; Farias MI; Viscente TA; Araújo RD; Melo EV; Aguiar-Oliveira MH
J Clin Endocrinol Metab; 2012 Mar; 97(3):1013-9. PubMed ID: 22170707
[TBL] [Abstract][Full Text] [Related]
6. Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.
Ciresi A; Amato MC; Guarnotta V; Lo Castro F; Giordano C
Clin Endocrinol (Oxf); 2013 Dec; 79(6):845-52. PubMed ID: 23506485
[TBL] [Abstract][Full Text] [Related]
7. One-hour post-load plasma glucose level is associated with a worse metabolic profile in children with GH deficiency.
Ciresi A; Giordano C
J Endocrinol Invest; 2018 Jul; 41(7):789-797. PubMed ID: 29249018
[TBL] [Abstract][Full Text] [Related]
8. Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiency.
Ferrante E; Malavazos AE; Giavoli C; Ermetici F; Coman C; Bergamaschi S; Profka E; Briganti S; Ronchi CL; Passeri E; Corbetta S; Lania AG; Spada A; Iacobellis G; Ambrosi B; Beck-Peccoz P
Nutr Metab Cardiovasc Dis; 2013 May; 23(5):459-65. PubMed ID: 22118958
[TBL] [Abstract][Full Text] [Related]
9. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
[TBL] [Abstract][Full Text] [Related]
10. The metabolic profile in active acromegaly is gender-specific.
Ciresi A; Amato MC; Pivonello R; Nazzari E; Grasso LF; Minuto F; Ferone D; Colao A; Giordano C
J Clin Endocrinol Metab; 2013 Jan; 98(1):E51-9. PubMed ID: 23162101
[TBL] [Abstract][Full Text] [Related]
11. Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort.
Martin RM; Holly JM; Davey Smith G; Gunnell D
J Clin Endocrinol Metab; 2006 Sep; 91(9):3287-95. PubMed ID: 16787980
[TBL] [Abstract][Full Text] [Related]
12. Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma.
Ferraù F; Spagnolo F; Cotta OR; Cannavò L; Alibrandi A; Russo GT; Aversa T; Trimarchi F; Cannavò S
Endocrine; 2017 Nov; 58(2):295-302. PubMed ID: 27981514
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV risk.
Reyes-Vidal C; Fernandez JC; Bruce JN; Crisman C; Conwell IM; Kostadinov J; Geer EB; Post KD; Freda PU
J Clin Endocrinol Metab; 2014 Nov; 99(11):4124-32. PubMed ID: 25137427
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
15. Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients.
Diazzi C; Brigante G; Ferrannini G; Ansaloni A; Zirilli L; De Santis MC; Zona S; Guaraldi G; Rochira V
Endocrine; 2017 Mar; 55(3):885-898. PubMed ID: 27730472
[TBL] [Abstract][Full Text] [Related]
16. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity.
Wasada T; Kasahara T; Wada J; Jimba S; Fujimaki R; Nakagami T; Iwamoto Y
Metabolism; 2008 Jul; 57(7):980-5. PubMed ID: 18555841
[TBL] [Abstract][Full Text] [Related]
18. New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese.
Jabłonowska-Lietz B; Wrzosek M; Włodarczyk M; Nowicka G
Kardiol Pol; 2017; 75(11):1185-1191. PubMed ID: 28715064
[TBL] [Abstract][Full Text] [Related]
19. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors.
Melmer A; Lamina C; Tschoner A; Ress C; Kaser S; Laimer M; Sandhofer A; Paulweber B; Ebenbichler CF
Obesity (Silver Spring); 2013 Apr; 21(4):775-81. PubMed ID: 23712981
[TBL] [Abstract][Full Text] [Related]
20. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
